Advertisement
Singapore markets closed

  • Straits Times Index

    3,410.81
    -29.07 (-0.85%)
     

  • Nikkei

    40,912.37
    -1.28 (-0.00%)
     

  • Hang Seng

    17,799.61
    -228.67 (-1.27%)
     

  • FTSE 100

    8,203.93
    -37.33 (-0.45%)
     

  • Bitcoin USD

    57,668.08
    +904.58 (+1.59%)
     

  • CMC Crypto 200

    1,196.06
    -12.63 (-1.04%)
     

  • S&P 500

    5,567.19
    +30.17 (+0.54%)
     

  • Dow

    39,375.87
    +67.87 (+0.17%)
     

  • Nasdaq

    18,352.76
    +164.46 (+0.90%)
     

  • Gold

    2,399.80
    +30.40 (+1.28%)
     

  • Crude Oil

    83.44
    -0.44 (-0.52%)
     

  • 10-Yr Bond

    4.2720
    -0.0830 (-1.91%)
     

  • FTSE Bursa Malaysia

    1,611.02
    -5.73 (-0.35%)
     

  • Jakarta Composite Index

    7,253.37
    +32.48 (+0.45%)
     

  • PSE Index

    6,492.75
    -14.74 (-0.23%)
     

Alcon to pay Johnson & Johnson $199 million to settle eye-laser cases

Blake Brittain
·2-min read
FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York

By Blake Brittain

(Reuters) - Alcon Vision LLC will pay Johnson & Johnson's J&J Surgical Vision Inc $199 million to settle legal battles over intellectual property related to the companies' laser eye-surgery devices, Alcon said in a press release on Sunday.

Alcon said the one-time payment would resolve "various worldwide intellectual property disputes" and that the companies had reached a cross-licensing agreement.

Representatives for Johnson & Johnson did not immediately respond to a request for comment Monday on the settlement.

A copyright trial was set to begin this week in Delaware federal court over claims that Alcon stole software from J&J's iFS Laser system, used for LASIK vision correction and other surgeries, and utilized it in Alcon's LenSx system to treat cataracts. A J&J expert had argued that the company was entitled to at least $3.1 billion in damages.

ADVERTISEMENT

Both companies also accused each other of patent infringement in claims that had been put on hold by the Delaware court.

New Brunswick, New Jersey-based J&J's Catalys laser cataract surgery system competes with LenSx.

AMO Development LLC, which J&J acquired in 2017, sued Alcon in 2020 for allegedly stealing thousands of lines of its source code. It accused Alcon in a 2021 court filing of committing "theft and deception on a grand and shocking scale - of the type usually found in paperback novels and Hollywood movies, not real-life disputes between publicly traded companies."

J&J said Alcon left "smoking guns" in its code that showed its theft, like typographical errors identical to those in J&J's code and comments dating from before LenSx development started.

U.S. District Judge Colm Connolly said during a 2021 hearing that there was "overwhelming" evidence that Alcon intentionally copied J&J's code.

Fort Worth, Texas-headquartered Alcon had denied the allegations.

The case is AMO Development LLC v. Alcon Vision LLC, U.S. District Court for the District of Delaware, No. 1:20-cv-00842

(Reporting by Blake Brittain in Washington)